Cara Therapeutics Inc CARA:NASDAQ

Last Price$17.18NASDAQ Closing Price as of 4:00PM ET 2/19/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-0.005(0.03%)
Bid (Size)$16.98 (16)
Ask (Size)$17.48 (20)
Day Low / High$16.86 - 17.29
Volume305.3 K
ValuationIndustry Range
Price / Earnings N/A
1.88597.80
Book Value 3.32
 
-32.26119.82
Earnings Per Share -$2.39
 
-74.4428.12
Price To Sales Ratio 40.72
 
0.6814.7K
Price To Book Ratio 5.82
 
N/A229.0K
Price To Tangible Book Ratio 5.82
 
0.40114.63
Price/Cash Flow Ratio N/A
4.892.3K
Price/Free Cash Flow Ratio N/A
6.28124.51
ProfileIndustry Range
Market Capitalization 805.2M
 
1.0M130.5B
Float (MRQ)78.08%
 
0.73106.55
Shares Outstanding (MRQ)44.5M
 
252.2 K1.3 B
Short Interest as a % of Float (MRQ)10.75%
 
N/AN/A
Shares Held By Institutions (MRQ)28.8M
 
0.73106.55
MarginsIndustry Range
Sales $20.9M
 
361.0K5.7B
Gross Margin N/A
-3.5K98.92
Net Profit Margin -470.70%
 
-500.9K1.5K
EBIT Margin -495.92%
 
-563.7K65.11
EBITDA Margin -492.83%
 
-561.2K71.75
Operating Margins -495.92%
 
-563.7K65.11
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K statement or press releases. MRQ = Most Recent Quarter
Financial StrengthIndustry Range
Current Ratio (MRQ)4.16
 
0.0966.40
Quick Ratio (MRQ)4.16
 
0.0966.40
Total Debt/Equity Ratio (MRQ)2.15
 
0.001,460,694.54
Debt/Common Equity Ratio (MRQ)2.15
 
0.001,460,694.54
EffectivenessIndustry Range
Return on Equity -70.35%
 
-4.3K87.77
Return on Assets -61.46%
 
-3.1K66.39
Asset Turnover 0.13
 
0.002.80
Receivables Turnover N/A
0.00373.92
Inventory Turnover N/A
0.15513.00
Earnings and DividendsIndustry Range
EPS Growth Annual 21.83%
 
N/AN/A
Dividend Yield 5 Year Average 0.00%
 
0.0012.44
Current Dividend Yield 0.00%
 
0.63 3.92
Current Payout Ratio N/A
0.0061.30
*CARA does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 0.85%